Skip to content
10-Q

Quarterly Report

Jade Biosciences, Inc. JBIO

0001193125-25-179853

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 32.63M sh
Shares Diluted Q2 2025 · Jun 30, 2025 28.43M sh
Shares Diluted Q2 2025 · Jun 30, 2025 15.93M sh
Shares Diluted Q2 2025 · Jun 30, 2024 3.16M sh
Capex Q2 2025 · Jun 30, 2025 $136K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$38.92M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $0
Cash And Equivalents Q2 2025 · Jun 30, 2025 $220.94M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $69.39M
Stockholders Equity Q2 2025 · Jun 30, 2025 $201.56M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$83.51M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$46.8M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 −$589K
Stockholders Equity Q2 2025 · Jun 17, 2024 −$1K
Current Liabilities Q2 2025 · Jun 30, 2025 $21.62M
Current Liabilities Q2 2025 · Dec 31, 2024 $12M
Total Liabilities Q2 2025 · Jun 30, 2025 $22.41M
Total Liabilities Q2 2025 · Dec 31, 2024 $119.6M
Current Assets Q2 2025 · Jun 30, 2025 $222.98M
Current Assets Q2 2025 · Dec 31, 2024 $69.65M
Total Assets Q2 2025 · Jun 30, 2025 $223.97M
Total Assets Q2 2025 · Dec 31, 2024 $72.8M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.86
Eps Diluted Q2 2025 · Jun 30, 2025 −$3.45
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.19
Eps Basic Q2 2025 · Jun 30, 2025 −$0.86
Eps Basic Q2 2025 · Jun 30, 2025 −$3.45
Eps Basic Q2 2025 · Jun 30, 2024 −$0.19
Sga Expense Q2 2025 · Jun 30, 2025 $5.23M
Sga Expense Q2 2025 · Jun 30, 2025 $8.59M
Sga Expense Q2 2025 · Jun 30, 2024 $512K
Rd Expense Q2 2025 · Jun 30, 2025 $22.55M
Rd Expense Q2 2025 · Jun 30, 2025 $42.57M
Rd Expense Q2 2025 · Jun 30, 2024 $78K
Net Income Q2 2025 · Jun 30, 2025 −$32.13M
Net Income Q2 2025 · Jun 30, 2025 −$70.3M
Net Income Q2 2025 · Mar 31, 2025 −$38.17M
Net Income Q2 2025 · Jun 30, 2024 −$590K
Operating Income Q2 2025 · Jun 30, 2025 −$27.78M
Operating Income Q2 2025 · Jun 30, 2025 −$51.16M
Operating Income Q2 2025 · Jun 30, 2024 −$590K